HiTMab - Monoclonal Antibody Discovery Solutions

MedGenome’s HiTMab (High-throughput monoclonal antibody discovery) platform based on its proprietary single cell genomics technology enables identification of multiple antigen specific B cells against a target. The whitepaper discusses the features of HitMab in speeding up the discovery of validated antibodies.